Healthcare & Medical
Category / Healthcare & Medical
Hong Kong: To Accelerate Commercialisation and Global Expansion
...
Hong Kong: HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus ...
Hong Kong: HONG KONG, Oct 9, 2025 - (ACN Newswire) - Everest Medicines today announced that the results of its Asian multicenter Phase III ENLIGHT UC study (ES101002) of etrasimod (VELSIPITY(R)) for the treatmen ...
TOKYO: TOKYO, Oct 29, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the launch of ...
TOKYO & HAMBURG: THUNDERBEAT™ II features the versatility of three energy modes to support surgeons in adapting to challenging clinical conditions ...
BANDUNG, INDONESIA: The 26th DCVMN Annual General Meeting, held in Bali on 29-31 October, marks a moment for Indonesia to reaffirm leadership in global health diplomacy ...
TOKYO: TOKYO, Oct 21, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), today announced that the feasibility study project entitled “Feasibility study on the development of Japanese digitalized endosc ...
TOKYO & HAMBURG: TOKYO & HAMBURG, Oct 6, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced t ...
TOKYO: Unlocking the Power of Intelligent Endoscopy. AI-powered tools help clinicians detect GI lesions earlier and improve care pathways ...
TOKYO: TOKYO, Sept 30, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced a new collabo ...
Hong Kong: HONG KONG, Sep 17, 2025 - (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapi ...
KUALA LUMPUR,: KUALA LUMPUR, Sept 18, 2025 - (ACN Newswire) - The Muslim Consumers’ Association of Malaysia today expressed deep concern over the emergence of counterfeit health products sold online with fake hala ...
Hong Kong: HONG KONG, Sep 15, 2025 - (ACN Newswire) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade, with the total number of related businesses now exceeding 3,000. Details of this r ...
HONG KONG: HONG KONG, Sep 1, 2025 - (ACN Newswire) - On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company’s total revenue for the first ha ...
HONG KONG: HONG KONG, Aug 14, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Appl ...
